Fluvac Innovator 6 Vaccine, Pre-Loaded Syringe

Supplied By: Zoetis (10016533)


SKU
020985


Unit of
Measure 12 x 1 Dose


Pack
Type Box


Case
Qty 1

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023
{{purchaseHistoryItem}}


SKU 020985


Size 12 x 1 Dose

Case
Qty 1

Purchase History

May- 2024 {{productPurchaseHistory['020985'][0]}} Oct- 2023 {{productPurchaseHistory['020985'][0+7]}}
Apr- 2024 {{productPurchaseHistory['020985'][1]}} Sep- 2023 {{productPurchaseHistory['020985'][1+7]}}
Mar- 2024 {{productPurchaseHistory['020985'][2]}} Aug- 2023 {{productPurchaseHistory['020985'][2+7]}}
Feb- 2024 {{productPurchaseHistory['020985'][3]}} Jul- 2023 {{productPurchaseHistory['020985'][3+7]}}
Jan- 2024 {{productPurchaseHistory['020985'][4]}} Jun- 2023 {{productPurchaseHistory['020985'][4+7]}}
Dec- 2023 {{productPurchaseHistory['020985'][5]}} May- 2023 {{productPurchaseHistory['020985'][5+7]}}
Nov- 2023 {{productPurchaseHistory['020985'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Fluvac Innovator® vaccines deliver demonstrated protection against circulating contemporary equine influenza viruses (EIV). Fluvac Innovator vaccines aid in the prevention of equine influenza due to type A2 viruses; encephalomyelitis due to Eastern, and Western viruses; and tetanus.

Features & Benefits

  • Vaccination before exposure is the best way to combat EIV
  • At-risk horses (those less than 6 years of age, senior horses and horses that may be frequently exposed to EIV at outside events) should be vaccinated for EIV every six months
  • Fluvac Innovator is the only vaccine with EIV strain KY/97 that has demonstrated protection against heterologous challenge with EIV strain OH/03
  • In a study, Fluvac Innovator has been shown to be cross-reactive against three newly emerging equine influenza viruses, including Ayrshire 2013 (AY/13) a European Clade 2 isolate, Kentucky 2014 (KY/14), and Texas 2012 (TX/12) recent North American Clade 1 isolates
  • Fluvac Innovator is the only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge
  • In addition to helping protect against EIV, Fluvac Innovator vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis
  • Only Innovator vaccines are adjuvanted with MetaStim® to help amplify the horse’s immune response